What Is Urinary Iodine? Normal vs Optimal Range Explained

Iodine deficiency remains the number one preventable cause of intellectual disability worldwide and the most common cause of preventable thyroid disease. The WHO classifies urinary iodine into four tiers: adequate (100–199 µg/L), mild deficiency (50–99 µg/L), moderate deficiency (20–49 µg/L), and severe deficiency (below 20 µg/L). The CTD maps over 180 compound interactions affecting iodine metabolism and thyroid hormone synthesis pathways. Unlike most biomarkers where the lab normal range is wider than optimal, urinary iodine's adequate range of 100–199 µg/L IS the optimal range—both too little and too much iodine cause thyroid dysfunction. Approximately two billion people globally have insufficient iodine intake, and while iodized salt programs have dramatically reduced severe deficiency in developed nations, mild deficiency persists in populations that have shifted away from iodized salt toward sea salt, Himalayan salt, and processed foods prepared without iodized salt.

Iodine is the rate-limiting substrate for thyroid hormone synthesis. Your thyroid gland concentrates iodine from the bloodstream at 20–50 times plasma levels using the sodium-iodide symporter, then incorporates it into thyroglobulin to produce T4 and T3. PubMed indexes over 32,000 publications on iodine status and thyroid function. When iodine intake falls below 100 µg/day, the thyroid cannot produce adequate hormone, triggering compensatory TSH elevation that drives thyroid enlargement (goiter). In pregnancy, even mild iodine deficiency impairs fetal neurodevelopment because the developing brain depends entirely on maternal thyroid hormone during the first trimester before the fetal thyroid becomes functional. The WHO recommends 250 µg/day for pregnant and lactating women—significantly higher than the 150 µg/day adequate for non-pregnant adults—because both maternal and fetal thyroid demands must be met simultaneously.

Excess iodine above 300 µg/L carries its own risks, particularly for individuals with underlying autoimmune thyroid disease. FAERS data document thyroid adverse events associated with iodine-containing medications including amiodarone and iodinated contrast media. The Wolff-Chaikoff effect describes how high iodine concentrations acutely suppress thyroid hormone synthesis as a protective mechanism, but in susceptible individuals—particularly those with Hashimoto's thyroiditis—this can trigger permanent hypothyroidism or thyrotoxicosis. Halide competitors including fluoride, bromide, and perchlorate can displace iodine from the sodium-iodide symporter, reducing thyroid iodine uptake even when dietary iodine appears adequate. Spot urinary iodine varies considerably throughout the day based on recent dietary intake, which is why serial measurements or a 24-hour urine collection provides more reliable assessment than a single random sample.